gross profit bridgeinconsistent2023-06-30
Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.
Revenue
$93.54M
Fiscal year ended 2026-07-03Operating income
$10.10M
Fiscal year ended 2026-07-03Free cash flow
$19.20M
Fiscal year ended 2026-07-03STAAR SURGICAL CO (STAA) reported revenue of $93.54M and net income of $8.06M for the fiscal year ended 2026-07-03. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from STAAR SURGICAL CO’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Ophthalmic Goods.
Income
| Metric | 2026-07-03 | 2026-04-03 | 2026-01-02 | 2025-09-26 | 2025-06-27 | 2025-03-28 | 2024-12-27 | 2024-09-27 | 2024-06-28 | 2024-03-29 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $93.54M | $93.52M | $57.80M | $94.73M | $44.32M | $42.59M | $48.95M | $88.59M | $99.00M | $77.36M |
| Cost of revenue | $23.81M | $24.66M | $14.06M | $16.86M | $11.52M | $14.58M | $17.30M | $20.10M | $20.59M | $16.32M |
| Gross profit | $69.73M | $68.86M | $43.74M | $77.88M | $32.80M | $28.00M | $31.65M | $68.49M | $78.41M | $61.04M |
| Operating income | $10.10M | $7.98M | -$22.84M | $18.49M | -$29.96M | -$57.40M | -$27.91M | $5.68M | $11.90M | -$2.28M |
| Net income | $8.06M | $5.21M | -$18.31M | $8.88M | -$16.81M | -$54.21M | -$34.23M | $9.98M | $7.38M | -$3.34M |
| Research & development | $9.94M | $9.92M | $9.24M | $9.21M | $10.26M | $11.34M | $9.77M | $12.25M | $11.87M | $13.38M |
| Weighted-average diluted shares | shares 51.50M | shares 50.90M | Unavailable | shares 50.55M | shares 49.52M | shares 49.34M | Unavailable | shares 49.73M | shares 49.81M | shares 48.91M |
| Pretax income | $11.02M | $8.22M | -$20.65M | $18.79M | -$25.92M | -$54.49M | -$30.33M | $13.16M | $10.33M | -$2.21M |
| Income tax expense | $2.97M | $3.01M | -$2.34M | $9.91M | -$9.10M | -$275.00K | $3.89M | $3.18M | $2.96M | $1.13M |
| Diluted EPS | $0.16 | $0.10 | Unavailable | $0.18 | $-0.34 | $-1.10 | Unavailable | $0.20 | $0.15 | $-0.07 |
| Selling, general & administrative | $59.63M | $60.88M | $66.58M | $59.38M | $62.76M | $85.41M | $59.56M | $62.80M | $66.51M | $63.32M |
| General & administrative | $22.74M | $17.02M | $19.59M | $20.76M | $20.97M | $24.46M | $21.34M | $21.68M | $23.64M | $23.23M |
| Selling & marketing | $26.94M | $24.51M | $25.84M | $23.46M | $26.28M | $26.94M | $28.44M | $28.87M | $31.00M | $26.71M |
Balance
| Metric | 2026-07-03 | 2026-04-03 | 2026-01-02 | 2025-09-26 | 2025-06-27 | 2025-03-28 | 2024-12-27 | 2024-09-27 | 2024-06-28 | 2024-03-29 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $148.58M | $131.86M | $153.15M | $176.16M | $167.13M | $173.11M | $144.16M | $164.00M | $192.78M | $224.02M |
| Total assets | $475.20M | $451.12M | $451.68M | $456.36M | $437.78M | $457.36M | $509.52M | $537.59M | $512.74M | $492.54M |
| Current assets | $342.35M | $312.40M | $311.54M | $321.21M | $292.79M | $326.50M | $367.94M | $397.11M | $383.82M | $365.72M |
| Total liabilities | $109.81M | $98.75M | $107.49M | $102.58M | $101.21M | $107.39M | $112.19M | $109.47M | $103.64M | $99.75M |
| Current liabilities | $73.39M | $60.99M | $68.50M | $61.64M | $59.23M | $68.36M | $70.31M | $66.34M | $66.17M | $62.67M |
| Total equity incl. NCI | $365.40M | $352.37M | $344.18M | $353.78M | $336.57M | $349.97M | $397.34M | $428.12M | $409.10M | $392.79M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $98.48M | $81.17M | $50.06M | $60.10M | $34.44M | $39.95M | $77.90M | $104.51M | $93.80M | $64.60M |
| Goodwill | $1.79M | $1.79M | $1.79M | $1.79M | $1.79M | $1.79M | $1.79M | $1.79M | $1.79M | $1.79M |
| Long-term debt | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts payable | $13.48M | $8.70M | $11.57M | $9.18M | $12.34M | $11.46M | $16.70M | $14.69M | $19.06M | $16.56M |
Cash flow
| Metric | 2026-07-03 | 2026-04-03 | 2026-01-02 | 2025-09-26 | 2025-06-27 | 2025-03-28 | 2024-12-27 | 2024-09-27 | 2024-06-28 | 2024-03-29 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $19.69M | -$21.70M | -$3.91M | $2.67M | -$27.25M | -$5.73M | $642.00K | $3.82M | -$10.41M | $21.68M |
| Capital expenditures | $494.00K | $443.00K | $1.68M | $883.00K | $1.79M | $1.47M | $5.72M | $6.23M | $6.24M | $5.20M |
| Investing cash flow | -$1.37M | $2.15M | -$19.42M | $5.28M | $25.12M | $35.35M | -$19.50M | -$35.24M | -$20.67M | $16.19M |
| Financing cash flow | -$1.50M | -$1.69M | -$50.00K | $983.00K | -$4.54M | -$948.00K | -$110.00K | $1.62M | $163.00K | $4.06M |
| Net change in cash | $16.72M | -$21.29M | -$23.00M | $9.02M | -$5.98M | $28.96M | -$19.84M | -$28.77M | -$31.25M | $40.99M |
| Stock-based compensation | $6.56M | $4.82M | $8.61M | $8.16M | $7.80M | $6.02M | $4.67M | $7.16M | $9.04M | $6.34M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | $0 | $1.98M | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2026-07-03 | 2026-04-03 | 2026-01-02 | 2025-09-26 | 2025-06-27 | 2025-03-28 | 2024-12-27 | 2024-09-27 | 2024-06-28 | 2024-03-29 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $19.20M | -$22.14M | -$5.59M | $1.78M | -$29.04M | -$7.20M | -$5.08M | -$2.42M | -$16.65M | $16.48M |
| Gross margin | 74.5% | 73.6% | 75.7% | 82.2% | 74.0% | 65.8% | 64.7% | 77.3% | 79.2% | 78.9% |
| Operating margin | 10.8% | 8.5% | -39.5% | 19.5% | -67.6% | -134.8% | -57.0% | 6.4% | 12.0% | -2.9% |
| FCF margin | 20.5% | -23.7% | -9.7% | 1.9% | -65.5% | -16.9% | -10.4% | -2.7% | -16.8% | 21.3% |
| SBC / revenue | 7.0% | 5.2% | 14.9% | 8.6% | 17.6% | 14.1% | 9.5% | 8.1% | 9.1% | 8.2% |
| Current ratio | 4.66x | 5.12x | 4.55x | 5.21x | 4.94x | 4.78x | 5.23x | 5.99x | 5.80x | 5.84x |
| Revenue YoY growth | 111.0% | 119.6% | 18.1% | 6.9% | -55.2% | -44.9% | -35.8% | 10.3% | Unavailable | 5.2% |
| Net margin | 8.6% | 5.6% | -31.7% | 9.4% | -37.9% | -127.3% | -69.9% | 11.3% | 7.5% | -4.3% |
| R&D / revenue | 10.6% | 10.6% | 16.0% | 9.7% | 23.2% | 26.6% | 20.0% | 13.8% | 12.0% | 17.3% |
| CapEx / revenue | 0.5% | 0.5% | 2.9% | 0.9% | 4.0% | 3.4% | 11.7% | 7.0% | 6.3% | 6.7% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 26.9% | 36.7% | Unavailable | 52.7% | Unavailable | Unavailable | Unavailable | 24.2% | 28.6% | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open STAA in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-12View SEC filing
10-Q · Filed 2026-05-13View SEC filing
10-K · Filed 2026-03-03View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-07View SEC filing
Reconciliation checks needing review
4 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationinconsistent2023-06-30
Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.
balance equationreview2023-03-31
Difference 3920000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2022-09-30
Difference 3010000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.